Gallagher Kathleen P. bought RNA
March 3, 2025 · Form 4 insider transaction
Gallagher Kathleen P. bought 5,875 shares of Atrium Therapeutics, Inc. at $14.70 per share, a transaction worth $86.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,875
Price
$14.70
Total value
$86.4K
InsiderGallagher Kathleen P.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 3, 2025
Filing dateMarch 4, 2025
Shares owned after56,429
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This option exercise and sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.